Option Care Health, Inc. (OPCH)
NASDAQ: OPCH · Real-Time Price · USD
32.97
+0.07 (0.21%)
At close: Apr 28, 2025, 4:00 PM
34.54
+1.57 (4.76%)
Pre-market: Apr 29, 2025, 8:42 AM EDT
Option Care Health Market Cap
Option Care Health has a market cap or net worth of $5.42 billion as of April 29, 2025. Its market cap has decreased by -0.63% in one year.
Market Cap
5.42B
Enterprise Value
6.35B
1-Year Change
-0.63%
Ranking
Category
Stock Price
$32.97
Market Cap Chart
Since December 1, 1998, Option Care Health's market cap has increased from $81.40M to $5.42B, an increase of 6,552.47%. That is a compound annual growth rate of 17.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 28, 2025 | 5.45B | 38.05% |
Dec 31, 2024 | 3.95B | -33.84% |
Dec 29, 2023 | 5.97B | 9.03% |
Dec 30, 2022 | 5.47B | 6.99% |
Dec 31, 2021 | 5.12B | 75.14% |
Dec 31, 2020 | 2.92B | 10.94% |
Dec 31, 2019 | 2.63B | 475.98% |
Dec 31, 2018 | 457.10M | 23.17% |
Dec 29, 2017 | 371.10M | 203.19% |
Dec 30, 2016 | 122.40M | 1.75% |
Dec 31, 2015 | 120.30M | -74.93% |
Dec 31, 2014 | 479.80M | -4.80% |
Dec 31, 2013 | 504.00M | -17.74% |
Dec 31, 2012 | 612.70M | 94.69% |
Dec 30, 2011 | 314.70M | 12.03% |
Dec 31, 2010 | 280.90M | -14.54% |
Dec 31, 2009 | 328.70M | 282.65% |
Dec 31, 2008 | 85.90M | -70.50% |
Dec 31, 2007 | 291.20M | 125.04% |
Dec 29, 2006 | 129.40M | -53.72% |
Dec 30, 2005 | 279.60M | 97.18% |
Dec 31, 2004 | 141.80M | -9.51% |
Dec 31, 2003 | 156.70M | 10.98% |
Dec 31, 2002 | 141.20M | -63.07% |
Dec 31, 2001 | 382.30M | 1,891.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 787.80B |
UnitedHealth Group | 382.29B |
Johnson & Johnson | 373.78B |
AbbVie | 340.25B |
Novo Nordisk | 280.41B |
Abbott Laboratories | 224.65B |
AstraZeneca | 218.53B |
Novartis AG | 214.73B |